Patent Assignment
Reel/Frame 053538/0623
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 50395/0398
Recorded: 2020-08-19
Pages: 19
Assignor
BPCR LIMITED PARTNERSHIP
Executed: 2020-08-18
Assignee
NOVOCURE GMBH
6 PARK, ROOT D4 6039, SWITZERLAND
Covered Properties
(73)
Method and Apparatus for Destroying Dividing Cells
Apparatus for Destroying Dividing Cells
Apparatus and Method for Treating a Tumor or the Like
Method and Apparatus for Destroying Dividing Cells
Apparatus for Treating a Tumor or the Like and Articles Incorporating the Apparatus for Treatment of the Tumor
Apparatus and Method for Optimizing Tumor Treatment Efficiency by Electric Fields
Treating a Tumor or the Like with an Electric Field That Is Focused at a Target Region
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating a Tumor or the Like with Electric Fields at Different Orientations
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Treating a Tumor or the Like with Electric Fields at Different Orientations
Apparatus and Method for Preventing the Spread of Cancerous Metastases and for Elimination of Metastases
Hat for Treating a Tumor or the Like
Probe for Treating a Tumor or the Like
Article of Clothing for Treating a Tumor or the Like
Apparatus for Selectively Destroying Dividing Cells
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Composite Electrode
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Bacteria with Electric Fields
Treating Parasites with Electric Fields
Method and Apparatus for Destroying Dividing Cells
Patent:
43,618 →
Application:
12/199,498 →
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Probe for Treating a Tumor or the Like
Treating Bacteria with Electric Fields
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Composite Electrode
Optimizing Treatment Using Ttfields by Changing the Frequency During the Course of Long Term Tumor Treatment
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
High Voltage, High Efficiency Sine Wave Generator with Pre-Set Frequency and Adjustable Amplitude
TTField Treatment with Optimization of Electrode Positions on the Head Based on MRI-Based Conductivity Measurements
Reducing Motility of Cancer Cells Using Tumor Treating Fields (TTFields)
Optimizing Treatment Using TTfields by Changing the Frequency During the Course of Long Term Tumor Treatment
Arrays for Longitudinal Delivery of TTFields to a Body
Arrays for Longitudinal Delivery of TTFields to a Body
Application:
15/636,736 →
Publication:
US 2018/0001075
Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
Application:
15/643,578 →
Publication:
US 2018/0008708
Temperature Measurement in Arrays for Delivering TTFields
Treating Patients with TTFields with the Electrode Positions Optimized Using Deformable Templates
System for Viewing Cell Cultures under a Microscope Whilst Applying TTFields
Delivering Tumor Treating Fields (TTFields) to the Infratentorial Brain
TTField Treatment with Optimization of Electrode Positions on the Head Based on MRI-Based Conductivity Measurements
Treating Tumors Using Ttfields Combined with a Kinase Inhibitor
Application:
62/654,679 →
Water Content-Based Electrical Properties Tomography (wEPT) for Modelling Delivery of Tumor Treating Fields (TTFields) to the Brain
Application:
62/655,670 →
Methods and Compositions for Treating Tumors with TTFields and Sorafenib
Application:
62/695,918 →
Inhibiting Viral Infection Using Alternating Electric Fields
Application:
62/695,925 →
Using Power Density Loss and Related Measures to Quantify the Dose of Tumor Treating Fields (TTFields)
Application:
62/700,080 →
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Application:
62/722,100 →
Treating Autoimmune Diseases Using an Alternating Electric Field to Reduce the Proliferation of T-Cells
Application:
62/728,174 →
Treating Tumors Using TTFields Combined with ABT-751
Application:
62/741,791 →
Generating Tumor Treating Fields (TTFields) with High Uniformity Throughout the Brain
Application:
62/745,689 →
Prevention and Treatment of Teratoma Formation for Stem Cell Therapies Using Tumor-Treating Fields
Application:
62/749,305 →
Delivering Tumor Treating Fields (TTFields) to the Spinal Cord
Application:
62/750,315 →
Using Power Density Loss and Related Measures to Quantify the Dose of Tumor Treating Fields (TTFields)
Application:
62/754,901 →
Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images
Application:
62/760,998 →
Arrays for Delivering Tumor Treating Fields (TTFields) with Selectively Addressable Sub-Elements
Application:
62/769,319 →
Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields)
Application:
62/772,867 →
Delivering Tumor Treating Fields (TTFields) to the Spinal Cord
Application:
62/781,358 →
Evaluating Quality of Segmentation of an Image into Different Types of Tissue
Application:
62/789,660 →
Treating Gastric Cancer Using TTFields Combined with FOLFOX or the Individual Constituents Thereof
Application:
62/808,923 →
Determining a Frequency for TTFields Treatment Based on an Electrical Characteristic of Targeted Cancer Cells
Application:
62/810,823 →
Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays
Application:
62/811,311 →
Treating Tumors with TTFields and an Aurora Kinase Inhibitor
Application:
62/826,114 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jul 11, 2012
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 028527/0432 →
Release of Security Interest
Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
Assignment of Assignor's Interest
Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
Change of Name
Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
Security Interest
Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
Release of Security Interest
Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
Security Interest
May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
Assignment of Assignor's Interest
Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
Release of Security Interest
Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 045278/0825
Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
Omnibus Confirmation of Assignment Agreement
May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 45278 0825
Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
Security Interest
Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
Release of Security Interest
Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement
May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →